Global Premenstrual Syndrome Treatment Market Research Report: Forecast (2024-2030)

Market Definition

A hormonal imbalance in women leads to premenstrual syndrome (PMS), which impacts their mental health. PMS is reflected through symptoms like stress, tension, sobbing, mood swings, etc. These problems are common in women in their monthly cycle and can be treated with PMS treatment medications such as ovarian suppression drugs, analgesics, antidepressants, and oral contraceptives. These remedies can be taken with or without a prescription and are often found in the drugstore.

Market Insights & Analysis: Global Premenstrual Syndrome Treatment Market (2024-30):

The Global Premenstrual Syndrome Treatment Market is estimated to grow at a CAGR of around 3.7% during the forecast period, i.e., 2024-30. The demand for Premenstrual Syndrome (PMS) treatment solutions has been increasing consistently across the globe in recent years. This has been primarily influenced by the adoption of unhealthy lifestyles by a large population of women across the globe, mainly in regions such as North America and Europe. Globally, instances of PMS have been observed specifically across countries that have a high working female population. This is primarily because working women are generally unable to take care of their physical and mental well-being, owing to the time constraints, which have been leading to a hormonal imbalance among them. Consequently, the symptoms of PMS have been mainly observed among working women. Further, PMS often leads to mental issues like anxiety, depression, stress, etc., which reduces the work efficiency of women. Hence, to reduce the effect of PMS on their work schedule, most women opt for PMS treatment solutions, which have been responsible for the market growth & expansion in recent years.

Furthermore, apart from the working women population, female students in college and universities often face the issue of premenstrual syndrome in their lives. The issue among female students is highly prominent in countries such as China, Japan, Turkey, etc., because of the factors related to their lifestyle, dietary habits, and genetics. Moreover, female students often face stress situations due to academic pressure, which leads to the worsening of the symptoms of PMS among them. Also, if such a syndrome persists for a longer duration, it affects their academic performance, and hence, they prefer to adopt PMS treatment solutions to recover. Henceforth, this type of problem has also been augmenting the size & volume of the PMS treatment industry during the historical years.

Additionally, with the rising disposable incomes, women have been observed to extensively incline toward unhealthy eating & drinking habits, like consumption of alcohol, junk food, and smoking among others. These unhealthy food items have been observed to trigger hormonal imbalances among most women, which further worsens their condition of premenstrual syndrome. Hence, as the adoption of unhealthy eating habits escalates among women, the instances of PMS would also improve, which would escalate the demand for PMS treatment solutions during the forecast period.

Global Premenstrual Syndrome Treatment Market Driver:

Growing Instances of Premenstrual Dysphoric Disorder (PMDD) Driving Market Growth – Globally, the instances of PMDD emerged as one of the major market drivers, which has been growing significantly, which is in particular due to the growing fitness issues among women. PMDD is the greater extreme shape of premenstrual syndrome, which often results in excessive bodily abnormalities, like belly pain, weight pain, swelling of breasts, and so forth. Also, the predominant aspect besides PMDD is intense hormonal balance, which is frequently related to the genetics of women. Further, consistent stress and other neurological conditions may also affect the hormonal balance among women, leading to PMDD. Henceforth, as the instances of PMDD have been escalating, the demand for treatment solutions has also amplified, which has been driving the market growth. This demand is also expected to grow in the forecast years, as the instance of PMDD would increase further.

Global Premenstrual Syndrome Treatment Market Opportunity:

Adoption of Digital Platforms for Better PMS Management to Offer Lucrative Opportunities – With the launch of women's health applications across the globe, specifically designed for tracking women's menstrual health, the demand for PMS treatment solutions is expected to grow in the forecast years. Several apps like Flo Health, Clue Period Tracker, etc., are available on smartphones for women to efficiently track their menstrual health cycle. These apps have recently started integrating more solutions, which further allow women to track their pre-menstrual syndrome, and also help them to manage their syndrome. Hence, these period-tracking apps make it quite easy for women to track their health status. Also, various organizations and government bodies across the globe, are conducting awareness programs to improve the awareness of women’s reproductive health. For instance,

• In 2023, the Knowledge Translation Unit (KTU) of the University of Cape Town (UCT) inspired its Brazilian counterparts to create the Unidade de tradução de conhecimento (UTC) to guarantee that primary healthcare providers in Brazil provide excellent patient care, which includes educating women about their health.

Due to such efforts, women would become aware of their reproductive health and would focus more on tracking their menstrual health and moods during the cycle.  Hence, with the improvement in the adoption of these platforms, women would become aware of PMS conditions, which would allow them to access PMS treatment solutions as well. Thus, the launch of menstrual tracking applications would create a lot of opportunities for the market players in the forthcoming years.

Global Premenstrual Syndrome Treatment Market Challenge:

Lack of Awareness & Challenges in Diagnostics – PMS is often challenging to diagnose, because of the unavailability of specific signs and symptoms, which are related to PMS only. This often poses challenges to the physical diagnosis of PMS. Moreover, there is also an unavailability of a specific diagnostic tool or methodology for the identification of PMS. Hence, their diagnosis often remains limited in comparison to other diseases.

Further, another fundamental challenge to the market growth is the lack of awareness among women regarding the effects and symptoms of PMS. Lack of cognizance is generally prominent among women living in remote areas, who are normally uneducated and lack know-how of the signs of PMS. Hence, with a lack of knowledge, and restricted treatment alternatives, women are mostly unaware of the fact that they have PMS. This often affects the demand for PMS treatment solutions negatively in the market and has been one of the major challenges for market growth. This challenge would continue to persist in upcoming years as well if governments across different countries do not focus on improving awareness regarding the PMS among women.

Global Premenstrual Syndrome Treatment Market Trend:

Growing Preference for Herbal Medicine & Nutritional Supplements – Due to inadequate symptom relief, unwanted side effects, etc., there has been increased dissatisfaction with conventional premenstrual syndrome treatments. This has led women to opt for herbal medicine and nutritional supplements such as Dynemo PMS Relief Herbal Tea, and Amorex Tablets having a potent combination of herbs, etc., to get adequate relief from premenstrual syndrome symptoms. This is mainly attributed to the advantages of herbal medicine, such as fewer side effects compared to conventional drugs that address multiple symptoms simultaneously.

Additionally, herbal medicines and nutritional supplements for premenstrual syndrome are often readily available over the counter in pharmacies and drug stores, which makes them easily accessible to individuals seeking relief from PMS symptoms. Hence, the increased preference for herbal medicine and nutritional supplements is changing market dynamics and augmenting the size & volume of the Premenstrual Syndrome Treatment Industry.

Global Premenstrual Syndrome Treatment  Market (2024-30): Segmentation Analysis

The Global Premenstrual Syndrome Treatment  Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment. It includes predictions for the period 2024–2030 at the global level. Based on the analysis, the market has been further classified as:

Based on the Drug Type

• Analgesics
• Antidepressants
• Oral Contraceptives
• Ovarian Suppression Agents
• Others (Diuretics, Herbal Supplements, etc.)

Out of them all, the oral contraceptives segment held a major market share. The market growth has been attributed to the occurrence of premenstrual syndrome among women of reproductive age. Further, a range of symptoms including bloating, stomach pain, headache, etc., hinders working women from effectively continuing their job. As a result, the demand for oral contraceptives such as Drospert by Torrent Pharmaceuticals Ltd. and Dronis P by Sun Pharmaceutical Industries Ltd. that reduce menstrual cramps and make periods lighter has seen growth among working women.

Additionally, several awareness programs and campaigns such as Safe N Happy Periods, Just a Period, etc., have created awareness of the importance of menstrual health and hygiene. These programs have made many women across various age groups aware of premenstrual syndrome and also available treatment options including oral contraceptives. Consequently, the demand for Oral Contraceptives has increased, propelling the segmental market growth.

Based on the Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Among them, the Online Pharmacies segment held a giant share in the Global Premenstrual Syndrome Treatment Market. There has been an upsurge in smartphone utilization and internet penetration internationally obtrusive from the reality that during 2023, 54% of the worldwide population, owned a smartphone, as mentioned through the Global System for Mobile Communications Association (GSMA). This has allowed a greater number of human beings to have access to online pharmacies for various medicines, thereby escalating the segmental market growth. Additionally, the availability of online payments and the convenience of getting medicines delivered at home have led to a higher dependency on online pharmacies.

Furthermore, the increasing number of online pharmacies is propelling segmental market growth. For instance, in 2024 Amazon launched same-day prescription delivery in New York and Los Angeles. Earlier, in 2023, MrMed, an online pharmacy launched a mobile app for access to affordable super-specialty medicines in India. As online pharmacies continue to innovate and expand their services across the world, access to essential medications would increase, driving the segmental market growth.

Global Premenstrual Syndrome Treatment  Market (2024-30): Regional Projections

Geographically, the Global Premenstrual Syndrome Treatment  Market expands across:

• North America
• South America
• Europe
• The Middle East & Rest of Africa
• Asia-Pacific

North America has been experiencing substantial growth in the Premenstrual Syndrome Treatment Industry in the past few years. This has been primarily attributed to the high cases of mental health conditions like bipolar issues, stress, anxiety, etc. observed among women across the region. The region has one of the maximum ratios of working women population, which has been responsible for the higher cases of mental health issues. Also, some other foremost issues causing the increase in mental fitness conditions in the region include the escalating adoption of unhealthy lifestyles among women. Women in this region have been observed to mostly follow sedentary lifestyles, and have been involved in consuming junk food, along with smoking and alcohol consumption. Hence, a lot of these elements were contributing to the upward thrust in mental health issues, which have been main to hormonal imbalances among women. Therefore, as a result of this, women throughout the region have been largely driving the demand for PMS medication in the past few years.

Global Premenstrual Syndrome Treatment Industry Recent Development:

• 2022: Lupin received the US Food and Drug Administration approval for the generic oral contraceptive pill Drospirenone.

Gain a Competitive Edge with Our Global Premenstrual Syndrome Treatment  Market Report

1. The Global Premenstrual Syndrome Treatment  Market Report by Markntel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. The Global Premenstrual Syndrome Treatment  Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.